Premier Inc.
04/09/2026 | Press release | Distributed by Public on 04/09/2026 13:48
Recent 340B Court Rulings Sustain Blocked WV Law, Demand Decade-Old Federal Policy Be Set Aside
*:last-child]:mb-0 [&>*:last-child]:pb-0 [&>p]:font-normal text-left [&>.prm-button-bar]:justify-start [&_.portable-text-link]:font-semibold [&_.portable-text-link]:underline [&_.prm-button-bar_a]:no-underline [&_li]:text-light-gray [&_p]:text-light-gray">
InsideHealthPolicy reports on two major court rulings shaping the future of the 340B program, including a decision in favor of Premier Inc. that vacates a longstanding federal drug purchasing policy. A Washington, D.C. federal court ruled that the Health Resources and Services Administration (HRSA) failed to adequately justify its 2013 policy restricting certain 340B hospitals from using group purchasing organizations for initial drug purchases.
Read more from InsideHealthPolicy.
Premier Inc. published this content on April 09, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 09, 2026 at 19:48 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]